The expression of osteoblast-specific factor 2 in the prostate cancer-related stroma was analyzed by laser capture microdissection of clinical specimens from prostate cancer patients by whole genome expression microarray technology (Wu et al., 2005). The gene discussed is POSTN; the disease is prostate cancer.